SEC Form 4 · accession 0000950157-16-002176
Evolent Health, Inc. · EVH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nicholas McGrane
Officer — Chief Financial Officer
Period of report
Sep 14, 2016
Accepted (ET)
Sep 15, 2016 · 4:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001628908
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Sep 14, 2016 | M | 21,205 | $3.84 | A | 136,495 | D | |
| Class A Common StockF1 | Sep 14, 2016 | S | 21,205 | $21.54 | D | 115,290 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Option (right to buy)F2 | $3.84 | Sep 14, 2016 | M | 21,205 | D | — | Oct 22, 2024 | Class A Common Stock | 21,205 | 278,795 | D |
Explanation of responses
- F1The price of $21.54 represents the public offering price of $22.50 per share of Class A Common Stock less the underwriters' discount of $0.96 per share.
- F2The Class A Common Stock Options exercised vested on November 1, 2015. One fourth of the Class A Common Stock Options granted to the reporting person on October 22, 2014 vested on November 1, 2015; the balance vested or vests at a rate of 6.25% as of the end of each three-month period immediately thereafter during the period beginning on the day following the first anniversary of the grant date.
Remarks
Exhibit 24.1 Power of Attorney dated July 8, 2015